Atomic Force Microscopy Images Label-Free, Drug Encapsulated Nanoparticles In Vivo and Detects Difference in Tissue Mechanical Properties of Treated and Untreated: A Tip for Nanotoxicology

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Lamprou, Dimitrios A ^a   Venkatpurwar, Vinod ^a   Kumar, M N V Ravi ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; NANOPARTICLE; POLYESTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATOMIC FORCE MICROSCOPY; CONTROLLED STUDY; DRUG TISSUE LEVEL; EX VIVO STUDY; IN VIVO STUDY; MALE; NANOENCAPSULATION; NANOPARTICLE LOCALIZATION; NANOTOXICOLOGY; NONHUMAN; PARTICLE SIZE; RAT; RIGIDITY; TISSUE CHARACTERIZATION; TISSUE DISTRIBUTION; TISSUE SECTION; TISSUE STIFFNESS; TOXICOKINETICS; YOUNG MODULUS;

ANIMALS; BIOMECHANICAL PHENOMENA; CYCLOSPORINE; DRUG COMPOUNDING; INTESTINE, SMALL; KIDNEY; LIVER; MICROSCOPY, ATOMIC FORCE; NANOMEDICINE; NANOPARTICLES; ORGAN SPECIFICITY; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; STAINING AND LABELING; TOXICOLOGY;

RODENTIA;

EID: 84878415750     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064490     Document Type: Article

References (26)

1. Moghimi SM, Wibroe PP, Helvig SY, Farhangrazi ZS, Hunter AC, (2012) Genomic perspectives in inter-individual adverse responses following nanomedicine administration: The way forward. Adv Drug Deliv Rev 64: 1385-1393.
2. Moghimi SM, Hunter AC, Murray JC, (2005) Nanomedicine: current status and future prospects. FASEB J 19: 311-330.
3. Geng Y, Dalhaimer P, Cai S, Tsai R, Tewari M, et al. (2007) Shape effects of filaments versus spherical particles in flow and drug delivery. Nature Nanotechnol 2: 249-255.
4. Nel AE, Mädler L, Velegol D, Xia T, Hoek EMV, et al. (2009) Understanding biophysicochemical interactions at the nano-bio interface. Nature Mater 8: 543-557.
5. Petros RA, DeSimone JM, (2010) Strategies in the design of nanoparticles for therapeutic applications. Nature Rev Drug Discov 9: 615-627.
6. De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJAM, Geertsma RE, (2008) Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29: 1912-1919.
7. Han M, Gao X, Su JZ, Nie S, (2001) Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules. Nature Biotechnol 19: 631-635.
8. Singh R, Pantarotto D, Lacerda L, Pastorin G, Klumpp C, et al. (2006) Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc Natl Acad Sci U S A 28: 3357-3362.
9. Park JH, Gu L, Von Maltzahn G, Ruoslahti E, Bhatia SN, Sailor MJ, (2009) Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nature Mater 8: 331-336.
10. Tong L, Lu Y, Lee RJ, Cheng JX, (2007) Imaging receptor-mediated endocytosis with a polymeric nanoparticle-based coherent anti-stokes Raman scattering probe. J Phys Chem B 111: 9980-9985.
11. Zhu Q, Talton J, Zhang G, Cunningham T, Wang Z, et al. (2012) Large intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection. Nature Med 18: 1291-1296.
12. Sengupta S, Eavarone D, Capila I, Zhao G, Watson N, et al. (2005) Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature 436: 568-572.
13. Sanhai WR, Sakamoto JH, Canady R, Ferrari M, (2008) Seven challenges for nanomedicine. Nature Nanotechnol 3: 242-244.
14. LaVan DA, McGuire T, Langer R, (2003) Small-scale systems for in vivo drug delivery. Nature Biotechnol 21: 1184-1191.
15. Forsyth AM, Wan J, Ristenpart WD, Stone HA, (2010) The dynamic behavior of chemically "stiffened" red blood cells in microchannel flows. Microvasc Res 80: 37-43.
16. Merchante N, Rivero-Juárez A, Téllez F, Merino D, José Ríos-Villegas M, et al. (2012) Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis. Hepatology 56: 228-238.
17. Shoji T, Emoto M, Shinohara K, Kakiya R, Tsujimoto Y, et al. (2001) Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol 12: 2117-2124.
18. Cross SE, Jin YS, Rao J, Gimzewski JK, (2007) Nanomechanical analysis of cells from cancer patients. Nature Nanotechnol 2: 780-783.
19. Plodinec M, Loparic M, Monnier CA, Obermann EC, Zanetti-Dallenbach R, et al. (2012) The nanomechanical signature of breast cancer. Nature Nanotechnol 7: 757-765.
20. Müller DJ, Dufrêne YF, (2008) Atomic force microscopy as a multifunctional molecular toolbox in nanobiotechnology. Nature Nanotechnol 3: 261-269.
21. Italia J, Bhatt D, Bhardwaj V, Tikoo K, Kumar MNVR, (2007) PLGA nanoparticles for oral delivery of cyclosporine: Nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral®, J Control Release. 119: 197-206.
22. Maugis D (2000) Contact, Adhesion and Rupture of Elastic Solids. Berlin: Springer-Verlag. 413 p.
23. Tsukada K, Sekizuka E, Oshio C, Minamitani H, (2001) Direct measurement of erythrocyte deformability in diabetes mellitus with a transparent microchannel capillary model and high-speed video camera system, Microvasc Res. 61: 231-239.
24. Kalaria D, Sharma G, Beniwal V, Kumar MNVR, (2009) Design of biodegradable nanoparticles for oral delivery of Doxorubicin: In vivo pharmacokinetics and toxicity studies in rats, Pharm Res. 26: 492-501.
25. Ratnam DV, Bhardwaj V, Kumar MNVR, (2013) Can controversial nanotechnology promise drug delivery? Chem Rev 113: 1686-1735.
26. Rosen H, Abribat T, (2005) The rise and rise of drug delivery. Nature Rev Drug Discov 4: 381-385.